- Home
- FHB vs CRNX Comparison
FHB vs CRNX Comparison
Compare FHB & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FHB
- CRNX
- Stock Information
- Founded
- FHB 1858
- CRNX 2008
- Country
- FHB United States
- CRNX United States
- Employees
- FHB N/A
- CRNX N/A
- Industry
- FHB Major Banks
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- FHB Finance
- CRNX Health Care
- Exchange
- FHB Nasdaq
- CRNX Nasdaq
- Market Cap
- FHB 3.3B
- CRNX 2.8B
- IPO Year
- FHB 2016
- CRNX 2018
- Fundamental
- Price
- FHB $25.73
- CRNX $35.61
- Analyst Decision
- FHB Sell
- CRNX Strong Buy
- Analyst Count
- FHB 9
- CRNX 7
- Target Price
- FHB $26.72
- CRNX $74.33
- AVG Volume (30 Days)
- FHB 1.0M
- CRNX 1.0M
- Earning Date
- FHB 10-24-2025
- CRNX 08-07-2025
- Dividend Yield
- FHB 4.04%
- CRNX N/A
- EPS Growth
- FHB 11.02
- CRNX N/A
- EPS
- FHB 1.93
- CRNX N/A
- Revenue
- FHB $805,018,000.00
- CRNX $1,392,000.00
- Revenue This Year
- FHB $10.45
- CRNX $489.51
- Revenue Next Year
- FHB $2.57
- CRNX $661.93
- P/E Ratio
- FHB $13.35
- CRNX N/A
- Revenue Growth
- FHB 0.27
- CRNX 0.51
- 52 Week Low
- FHB $20.32
- CRNX $24.10
- 52 Week High
- FHB $28.80
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- FHB 57.34
- CRNX 70.32
- Support Level
- FHB $25.33
- CRNX $30.25
- Resistance Level
- FHB $26.23
- CRNX $35.21
- Average True Range (ATR)
- FHB 0.47
- CRNX 1.41
- MACD
- FHB 0.10
- CRNX 0.65
- Stochastic Oscillator
- FHB 71.05
- CRNX 95.62
About FHB First Hawaiian Inc.
First Hawaiian Inc is a bank holding company. It provides a diversified range of banking services to consumer and commercial customers, including deposit products, lending services, and wealth management and trust services. The company offers a variety of deposit products to its customers, including checking and savings accounts and other types of deposit accounts. It provides commercial and industrial lending, including auto dealer flooring, commercial real estate, and construction lending. It also offers comprehensive consumer lending services focused on residential real estate lending, indirect auto financing, and other consumer loans. The company's segments are Retail Banking, Commercial Banking, and Treasury, and others of which key revenue is derived from Retail Banking.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.